Graham Hooper: Target your biggest cyber weak spot – human error
Passwords, processes and systems can only protect us so far and the human factor is often the weakness
- News
-
- Analysis
-
- Investments
-
-
-
Top story
-
-
-
- Video
-
Author: Portfolio Adviser
-
-
Alternative Thinking: The investment case for medical cannabis
In the first of an occasional spotlight on less traditional assets, Rahul Bhushan picks out the tailwinds supporting medical cannabis as an investment opportunity
-
Mark Preskett: This is a time to keep calm and see the positives
In this challenging environment, investors should put the significant market movements into perspective and remain level-headed
-
‘Don’t spend all day in your pyjamas’: WFH – with EQ Investors’ Sophie Kennedy
Continuing our regular series of how investment experts are dealing with the coronavirus fallout
-
John Monaghan: The need for clarity in ESG and responsible investing
Without common ESG terminology accepted and understood by investors, confusion is inevitable
-
‘I now combine audiobooks with my daily run’: WFH with Sanlam UK’s Paris Jordan
Continuing our regular series of how investment experts are dealing with the coronavirus fallout
-
Chris Robinson: Covid-19 – where will the losses legally fall?
The pandemic is leading to greater focus on what legal remedies exist if a contract can no longer be performed
-
‘Proximity to the kitchen’s a danger’: WFH – with James Klempster of Momentum
Continuing our regular series of how investment experts are dealing with the coronavirus fallout
-
Mash Patel: Covid-19 crisis exposes investment sector’s tech deficiencies
History may remember the pandemic as the catalyst for profound changes in working practices in investment
-
Ben Goss on risk: Four client conversations for today’s markets
Four key talking points for advisers when speaking to clients concerned about the market and their portfolio
-
‘Investors rightly dislike information vacuums’: WFH – with Rathbones’ David Coombs
Continuing our regular series of how investment experts are dealing with the coronavirus fallout
-
Rory Campbell-Lamerton: Bill Gates, Microsoft and the next epidemic
Companies bought today need to have core businesses strong enough to survive the tough times ahead